arrow
P

Paweł Szymański

Medical University of Lodz
H指数:23
被引数:2,154

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Anticancer activity of the new manganese(II), iron(II), nickel(II), copper(II), and zinc(II) complexes based on 1,2,4-triazoline-3-thione derivative

基于1,2,4-三唑啉-3-硫酮衍生物的新型锰(II)、铁(II)、镍(II)、铜(II)和锌(II)配合物的抗癌活性

2025-10-230
PRE
The Role of Nitric Oxide in HSV-1 Infection: The Use of an Inducible Nitric Synthase Inhibitor Aminoguanidine to Treat Neuroinflammation

一氧化氮在HSV-1感染中的作用:使用诱导型一氧化氮合酶抑制剂氨基胍治疗神经炎症

2025-09-270
OAAI
New cyclopentaquinoline and 3,5-dichlorobenzoic acid hybrids with neuroprotection against oxidative stress for the treatment of Alzheimer's disease

新的环戊喹啉和3,5-二氯苯甲酸杂合物具有抗氧化应激的神经保护作用,可治疗阿尔茨海默氏病

2023-01-118
OAAI
Antitumor Activity and Physicochemical Properties of New Thiosemicarbazide Derivative and Its Co(II), Ni(II), Cu(II), Zn(II) and Cd(II) Complexes

新型氨基硫脲衍生物及其Co(II),Ni(II),Cu(II),Zn(II) 和Cd(II) 配合物的抗肿瘤活性和理化性质

2022-04-227
OAAI
Novel tetrahydroacridine derivatives with iodobenzoic moieties induce G0/G1 cell cycle arrest and apoptosis in A549 non-small lung cancer and HT-29 colorectal cancer cells

具有碘苯甲酸部分的新型四氢吖啶衍生物在A549非小细胞肺癌和HT-29结直肠癌细胞中诱导G0/G1细胞周期阻滞和凋亡

2019-07-1627
OAAI
Tetrahydroacridine derivatives with dichloronicotinic acid moiety as attractive, multipotent agents for Alzheimer's disease treatment

具有二氯烟酸部分的四氢吖啶衍生物作为阿尔茨海默氏病治疗的有吸引力的多效药物

2018-02-0120
PREAI